Skip to main content
padlock icon - secure page this page is secure

Free Content Trends in drug-resistant tuberculosis after the implementation of the DOTS strategy in Shenzhen, China, 2000–2013

Download Article:
(PDF 577.4 kb)
SETTING: The DOTS strategy has been regarded as the most cost-effective way to stop the spread of tuberculosis (TB) since its launch by the World Health Organization.

OBJECTIVE: To estimate the effects of DOTS by tracking long-term trends in multidrug-resistant TB (MDR-TB).

DESIGN: A retrospective cohort study was conducted from 2000 to 2013 to analyse trends in resistance to anti-tuberculosis drugs and the effect of DOTS-based treatment in Shenzhen, China, using the χ2 test.

RESULTS: An overall MDR-TB rate of 4.2% was observed between 2000 and 2013, with an annual reduction of 0.16%. From 2000 to 2013, trends in resistance to isoniazid (INH), rifampicin (RMP) and MDR-TB declined significantly in new TB patients (P < 0.01), but not in retreatment cases. Sputum smear conversion rates after 2 months of treatment decreased significantly, in particular after 2007, in new and retreatment cases.

CONCLUSION: INH and RMP resistance and MDR-TB rates declined significantly, suggesting that DOTS-based programmes were successful in reducing drug resistance in new cases but not in retreatment cases. The decreasing sputum smear conversion rates may have been due to an increase in the number of migrants. These two findings suggest that TB is unlikely to be completely eliminated by 2050 in Shenzhen.
No Reference information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Keywords: DOTS; MDR-TB; migrants; trends; tuberculosis

Document Type: Research Article

Affiliations: 1: Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, National Institute of Drug Dependence, Peking University, Beijing 2: Shenzhen Chronic Disease Control Centre, Shenzhen 3: National Centre for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 4: Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing 5: Department of Biomedical Engineering, Peking University, Beijing, China 6: National Institute of Drug Dependence, Peking University, Beijing

Publication date: July 1, 2017

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease publishes articles on all aspects of lung health, including public health-related issues such as training programmes, cost-benefit analysis, legislation, epidemiology, intervention studies and health systems research. The IJTLD is dedicated to the continuing education of physicians and health personnel and the dissemination of information on lung health world-wide.

    To share scientific research of immediate concern as rapidly as possible, The Union is fast-tracking the publication of certain articles from the IJTLD and publishing them on The Union website, prior to their publication in the Journal. Read fast-track articles.

    Certain IJTLD articles are also selected for translation into French, Spanish, Chinese or Russian. These are available on the Union website.

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more